Valeant Pharmaceuticals reported $-410000000 in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US USD 1.62B 527M
Ani Pharmaceuticals ANIP:US USD -4243000 4.36M
Aurora Cannabis Inc ACB:CN CAD -65392000 13.79M
Biogen BIIB:US USD 550.4M 584.3M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Canopy Growth Corp WEED:CN CAD -261583000 39.78M
Corcept Therapeutics CORT:US USD 16.6M 18.01M
Danaher DHR:US USD 2.23B 660M
Drreddys Laboratories RDY:US INR 12.47B 1.34B
Eli Lilly And LLY:US USD 1.94B 486M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Gilead Sciences GILD:US USD 1.64B 149M
Horizon Pharma HZNP:US USD 120.41M 15.43M
JAZZ PHA JAZZ:US USD -240724000 221.08M
Nektar Therapeutics NKTR:US USD -59688000 639K
Pacira Pharmaceuticals PCRX:US USD -10102000 9.41M
Perrigo Ordinary Shares PRGO:US USD -23700000 25.7M
Phibro Animal Health PAHC:US USD 7.21M 3.35M
Prestige Brands PBH:US USD 51.95M 928K
Revance Therapeutics RVNC:US USD -145952000 61.26M
Supernus Pharmaceuticals SUPN:US USD 25.48M 23.73M
Valeant Pharmaceuticals VRX:CN USD -410000000 809M
Vertex Pharmaceuticals VRTX:US USD 818.9M 111.6M
Zoetis ZTS:US USD 461M 68M